Squarepoint’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9M | Buy |
+166,602
| New | +$20.9M | 0.02% | 391 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 3073 |
|
|
2024
Q4 | – | Sell |
-68,369
| Closed | -$7.88M | – | 3083 |
|
|
2024
Q3 | $7.88M | Buy |
+68,369
| New | +$7.88M | 0.01% | 561 |
|
|
2024
Q2 | – | Sell |
-30,806
| Closed | -$4.25M | – | 2807 |
|
|
2024
Q1 | $4.25M | Sell |
30,806
-49,375
| -62% | -$6.81M | 0.01% | 759 |
|
|
2023
Q4 | $10.6M | Buy |
80,181
+51,830
| +183% | +$6.83M | 0.02% | 432 |
|
|
2023
Q3 | $3.19M | Sell |
28,351
-89,646
| -76% | -$10.1M | 0.01% | 774 |
|
|
2023
Q2 | $11.1M | Sell |
117,997
-47,839
| -29% | -$4.51M | 0.03% | 338 |
|
|
2023
Q1 | $16.8M | Buy |
165,836
+132,314
| +395% | +$13.4M | 0.07% | 203 |
|
|
2022
Q4 | $4M | Sell |
33,522
-24,138
| -42% | -$2.88M | 0.02% | 537 |
|
|
2022
Q3 | $6.12M | Buy |
57,660
+44,656
| +343% | +$4.74M | 0.03% | 394 |
|
|
2022
Q2 | $1.27M | Sell |
13,004
-84,440
| -87% | -$8.23M | 0.01% | 941 |
|
|
2022
Q1 | $9.14M | Buy |
97,444
+35,300
| +57% | +$3.31M | 0.04% | 320 |
|
|
2021
Q4 | $5.29M | Buy |
62,144
+44,657
| +255% | +$3.8M | 0.01% | 509 |
|
|
2021
Q3 | $1.68M | Sell |
17,487
-1,753
| -9% | -$168K | ﹤0.01% | 864 |
|
|
2021
Q2 | $1.87M | Buy |
19,240
+16,393
| +576% | +$1.59M | 0.01% | 840 |
|
|
2021
Q1 | $277K | Sell |
2,847
-1,197
| -30% | -$116K | ﹤0.01% | 1939 |
|
|
2020
Q4 | $388K | Sell |
4,044
-9,795
| -71% | -$940K | ﹤0.01% | 1683 |
|
|
2020
Q3 | $1.33M | Buy |
+13,839
| New | +$1.33M | 0.02% | 802 |
|
|
2020
Q2 | – | Sell |
-31,660
| Closed | -$2.74M | – | 2344 |
|
|
2020
Q1 | $2.74M | Sell |
31,660
-52,824
| -63% | -$4.57M | 0.07% | 360 |
|
|
2019
Q4 | $9.08M | Sell |
84,484
-81,220
| -49% | -$8.73M | 0.05% | 321 |
|
|
2019
Q3 | $14.9M | Buy |
165,704
+127,195
| +330% | +$11.5M | 0.13% | 181 |
|
|
2019
Q2 | $3.25M | Sell |
38,509
-73,922
| -66% | -$6.24M | 0.03% | 582 |
|
|
2019
Q1 | $9.91M | Sell |
112,431
-29,583
| -21% | -$2.61M | 0.1% | 231 |
|
|
2018
Q4 | $10.1M | Buy |
142,014
+134,539
| +1,800% | +$9.61M | 0.12% | 216 |
|
|
2018
Q3 | $919K | Buy |
7,475
+2,183
| +41% | +$268K | 0.01% | 1031 |
|
|
2018
Q2 | $520K | Buy |
5,292
+1,159
| +28% | +$114K | 0.01% | 1169 |
|
|
2018
Q1 | $343K | Sell |
4,133
-76,098
| -95% | -$6.32M | 0.01% | 1250 |
|
|
2017
Q4 | $6.23M | Buy |
80,231
+60,328
| +303% | +$4.68M | 0.11% | 211 |
|
|
2017
Q3 | $1.22M | Buy |
19,903
+15,465
| +348% | +$948K | 0.02% | 649 |
|
|
2017
Q2 | $204K | Buy |
+4,438
| New | +$204K | ﹤0.01% | 1290 |
|
|
2016
Q4 | – | Sell |
-24,611
| Closed | -$1.25M | – | 1867 |
|
|
2016
Q3 | $1.25M | Sell |
24,611
-41,289
| -63% | -$2.09M | 0.08% | 292 |
|
|
2016
Q2 | $3M | Buy |
+65,900
| New | +$3M | 0.19% | 121 |
|
|
2016
Q1 | – | Sell |
-5,300
| Closed | -$300K | – | 1353 |
|
|
2015
Q4 | $300K | Buy |
+5,300
| New | +$300K | 0.03% | 794 |
|